Interferon alfa-n3 Terminated Phase 2 Trials for Recurrent Grade 1 Follicular Lymphoma / Recurrent Grade 2 Follicular Lymphoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00015912Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma